Global RNA Interference RNAi Drug Delivery Market Report

By www.regionalmarketresearch.com

Report Details

Report Name

Global RNA Interference RNAi Drug Delivery Market Research Report 2023(Status And Outlook) Story

Pages

118

Price

$ 2800

Features

Global RNA Interference RNAi Drug Delivery Market Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Metabolic disorders
Alnylam Pharmaceuticals Inc
Merck & Co. Inc
Access Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Calondo Pharmaceuticals Inc
Marina Biotech Inc
RXi Pharmaceuticals Corp
Quark Pharmaceuticals Inc
Silence Therapeutics plc
Tacere Therapeutics Inc
PhaseRx Inc
Sirnaomics Inc
Traversa Therapeutics Inc